Home › Compare › SIELF vs MRK

SIELF vs MRK: Dividend Comparison 2026

SIELF yields 329.08% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SIELF wins by $18528076456225804.00M in total portfolio value
10 years
SIELF
SIELF
● Live price
329.08%
Share price
$0.61
Annual div
$2.00
5Y div CAGR
81.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18528076456225804.00M
Annual income
$18,499,570,992,390,452,000,000.00
Full SIELF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — SIELF vs MRK

📍 SIELF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSIELFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SIELF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SIELF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SIELF
Annual income on $10K today (after 15% tax)
$27,972.03/yr
After 10yr DRIP, annual income (after tax)
$15,724,635,343,531,884,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, SIELF beats the other by $15,724,635,343,531,884,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SIELF + MRK for your $10,000?

SIELF: 50%MRK: 50%
100% MRK50/50100% SIELF
Portfolio after 10yr
$9264038228112902.00M
Annual income
$9,249,785,496,195,226,000,000.00/yr
Blended yield
99.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SIELF
No analyst data
Altman Z
0.7
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SIELF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSIELFMRK
Forward yield329.08% ✓2.81%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR81.5% ✓32.7%
Portfolio after 10y$18528076456225804.00M ✓$57.7K
Annual income after 10y$18,499,570,992,390,452,000,000.00 ✓$10,113.78
Total dividends collected$18526207050487964.00M ✓$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SIELF vs MRK ($10,000, DRIP)

YearSIELF PortfolioSIELF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$70,429$59,728.51$11,213$373.04+$59.2K → SIELF
2$788,906$713,547.67$12,667$512.06+$776.2K → SIELF
3$14,402,039$13,557,908.94$14,439$708.14+$14.39M → SIELF
4$435,250,537$419,840,355.62$16,640$988.16+$435.23M → SIELF
5$21,988,201,385$21,522,483,311.04$19,432$1,394.07+$21988.18M → SIELF
6$1,867,844,598,422$1,844,317,222,939.43$23,057$1,992.90+$1867844.58M → SIELF
7$267,752,409,179,362$265,753,815,459,050.56$27,889$2,894.79+$267752409.15M → SIELF
8$64,906,205,357,370,980$64,619,710,279,549,064.00$34,518$4,286.29+$64906205357.34M → SIELF
9$26,640,620,406,874,665,000$26,571,170,767,142,280,000.00$43,912$6,494.35+$26640620406874.62M → SIELF
10$18,528,076,456,225,805,000,000$18,499,570,992,390,452,000,000.00$57,714$10,113.78+$18528076456225804.00M → SIELF

SIELF vs MRK: Complete Analysis 2026

SIELF — Stock

Shanghai Electric Group Company Limited, an equipment manufacturing conglomerate, provides clean energy, new energy and environmental protection, and industrial equipment, and modern services in the People's Republic of China. It offers coal-fired power generation and corollary, gas-fired power generation, wind power, nuclear power, and energy storage equipment, as well as vessels for chemical industry. The company also provides elevators, electric motors and ramps, and industrial basic parts; intelligent manufacturing, and construction industrialization equipment; and power grid and industrial intelligent power supply system solutions. In addition, it offers energy, and environmental protection and automation engineering; industrial internet; financing leases and insurance brokerage; international trade; and property services. Shanghai Electric Group Company Limited was incorporated in 2004 and is based in Shanghai, the People's Republic of China. Shanghai Electric Group Company Limited is a subsidiary of Shanghai Electric (Group) Corporation.

Full SIELF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SIELF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SIELF vs SCHDSIELF vs JEPISIELF vs OSIELF vs KOSIELF vs MAINSIELF vs JNJSIELF vs ABBVSIELF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.